微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -2.32% | -409.33% | -544.44% | 116/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -0.36% | -149.32% | 93.23% | 104/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -5.32% | -276.74% | -817.24% | 114/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -0.58% | -123.67% | -177.33% | 106/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 0.75% | -56.14% | 2.74% | 91/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.73% | 4.29% | -75.75% | 81/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.01% | 3.08% | 22.86% | 81/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 2.45% | -5.77% | 43.27% | 83/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 1.71% | 12.5% | 144.29% | 81/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.7% | 6.06% | -76.03% | 84/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.92% | -25.32% | 12.31% | 86/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 2.6% | -4.06% | 71.05% | 93/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.52% | -3.18% | 130.3% | 95/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.66% | -35.29% | -83.12% | 97/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 3.91% | -42.58% | 44.28% | 100/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 2.71% | -47.58% | 72.61% | 102/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 1.57% | -49.84% | 53.92% | 102/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.02% | -51.89% | -85.02% | 90/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 6.81% | -34.01% | 31.72% | 97/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 5.17% | -24.75% | 65.18% | 92/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.13% | -32.4% | 47.64% | 99/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.12% | -11.67% | -79.46% | 72/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 10.32% | 39.65% | 50.22% | 88/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 6.87% | 48.38% | 48.38% | 63/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 4.63% | 133.84% | 92.92% | 74/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.4% | 727.59% | -67.52% | 35/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 7.39% | 2.5% | 59.61% | 90/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.63% | -1.7% | 133.84% | 51/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 1.98% | 1.02% | 582.76% | 62/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.29% | 52.63% | -95.98% | 54/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 7.21% | 52.75% | 53.08% | 80/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.71% | 34.57% | 140.31% | 37/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 1.96% | 27.27% | 931.58% | 51/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.19% | 46.15% | -95.97% | 51/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 4.72% | 23.88% | 34.86% | 85/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 3.5% | 20.69% | 127.27% | 42/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 1.54% | -28.7% | 1084.62% | 51/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 0.13% | 118.57% | -96.59% | 43/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 3.81% | -29.96% | 31.38% | 71/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 2.9% | -22.46% | 34.26% | 35/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 2.16% | -26.78% | 408.57% | 42/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | -0.7% | 76.74% | -112.87% | 33/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |